Sort
27,075 grants matching “cholesterol”
Atherosclerosis And Peripheral Apoliprotein E Synthesis
$555,908State University New York Stony Brook · R01 · FY2004 · HL
Macrophages and attenuation of inflammation resolution in APOL1 nephropathy
$555,803Pinelopi P. Kapitsinou · Northwestern University At Chicago · R01 · FY2025 · DK
Determinants and Consequences of Low Vitamin D in Populations of African Descent
$555,646Ramon Angel Durazo-Arvizu · Loyola University Chicago · R01 · FY2014 · DK
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy
$555,637Craig Lewis Duvall · Vanderbilt University · R01 · FY2023 · CA
Age-Associated Changes in Arterial Proteome and Aortic Smooth Muscle Signaling
$555,373Edward Lakatta · National Institute On Aging · ZIA · FY2019 · AG
Latinos Using Cardio Health Actions to Reduce Risk
$555,332Sheana S Bull · University Of Colorado Denver · U01 · FY2008 · HL
Ozone, oxysterols, and lung inflammation
$555,329Ilona Jaspers · Univ Of North Carolina Chapel Hill · R01 · FY2021 · ES
SOCRATES: SOCial Risk and diAbetes ouTcomEs Study
$555,241Seth A Berkowitz · Univ Of North Carolina Chapel Hill · R01 · FY2024 · DK
Ozone, oxysterols, and lung inflammation
$555,161Ilona Jaspers · Univ Of North Carolina Chapel Hill · R01 · FY2020 · ES
Leveraging behavioral economics to equitably implement cascade screening in individuals with familial hypercholesterolemia in partnership with the FH Foundation
$555,134Rinad Sary Beidas · Northwestern University At Chicago · R33 · FY2025 · HL
LXR as a Novel Therapeutic Target in Diabetic Retinopathy
$555,127Maria B Grant · University Of Alabama At Birmingham · R01 · FY2017 · EY
Community Based Obesity Prevention Among Black Women
$554,979Gary G Bennett · Duke University · R01 · FY2012 · DK
REVERSE CHOLESTEROL TRANSPORT IN HUMANS
$554,943Richard E. Ostlund · Washington University · R01 · FY2012 · HL
Modeling DNA Diversity in Reverse Cholesterol Transport
$554,940Charles F Sing · University Of Michigan At Ann Arbor · R01 · FY2010 · HL
HCC Risk Stratification in MAFLD Cirrhosis
$554,835Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2025 · CA
Atherogenic Patheways Mediated by FOXO
$554,526Domenico Accili · Columbia University Health Sciences · P01 · FY2007 · HL
Mechanistic function of HCV NS5A targeted by the potent inhibitors
$554,525Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2022 · AI
Mechanistic function of HCV NS5A targeted by the potent inhibitors
$554,525Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2024 · AI
Mechanistic function of HCV NS5A targeted by the potent inhibitors
$554,525Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2021 · AI
Mechanistic function of HCV NS5A targeted by the potent inhibitors
$554,525Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2023 · AI
What is Aquaporin-1's role in transport across large vessels walls?
$554,500David S Rumschitzki · Cuny City College · · FY2009 · BIO
PREMIER--LIFESTYLE INTERVEN FOR BLOOD PRESSURE CONTROL
$554,450Kaiser Foundation Research Institute · U01 · FY2001 · HL
Receptor-mediated Endocytosis-Mechanism and Function
$554,430Frederick R. Maxfield · Weill Medical Coll Of Cornell Univ · R37 · FY2009 · DK
Improving Cardiac Rehabilitation outcomes through mobile case management (iCARE)
$554,427Thomas Patrick Olson · Mayo Clinic Rochester · R01 · FY2021 · NR
Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis
$554,365Gianfranco D. Alpini · Indiana University Indianapolis · R01 · FY2020 · AA